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DETECTION OF ANTIGENS
summarizes several reported techniques for the detection of viral antigens. Gel diffusion, rheophoresis, and immunoelectrophoresis (IEOP) employ gels in which antigen and antibody move toward each other, resulting in a line of precipitation. Thin-layer immunoassay (TIA) involves the adsorption of a thin layer of globulins onto a polystyrene surface [1, 2] . This surface then has the characteristics of an immunosorbent which is able to bind antigens. The antigen/antibody interaction is visualized on the plate by exposing it to water vapor. Immune complexes are hydrophilic and the background is hydrophobic; thus differences in condensation patterns are easily recognizable to the naked eye. Latex agglutination (LA), indirect hemagglutination inhibition (IHI) or reverse passive hemagglutination (RPHA) , and solid-phase aggregation of coated erythrocytes (SPACE) [3] are all based on the principle of coating a visible marker such as latex particles or erythrocytes with antibody. These tests are usually performed by mixing specimens with the coated surfaces and allowing time for settling. SPACE is a solid phase variant of the test (Fig. 1 ). These tests are relatively rapid, sensitive, and simplistic. A commercially available LA test for rotaviruses has enabled the immediate processing of stool suspensions from children admitted to hospital with gastroenteritis during winter months when a large number of specimens are submitted to the laboratory (greater 757 Fig. 4: (1) competitive, (2) direct, or (3) indirect. In the competitive assay [9] , enzyme-labeled antigen is mixed with the test sample containing antigen, which competes for a limited amount of antibody attached to the solid phase. Unbound antigen is washed away and the difference in indicator activity between the specimen and the control is compared. In a direct assay the clinical specimen is added to a solid phase which has a CA attached to it. Unbound antigen is washed away before the addition of conjugated detector antibody (DA). The indirect test is similar to the direct assay employing a CA and DA, but the DA is not conjugated. Instead, a third conjugated IA, which is anti-species to DA, is used. This approach has become popular for ELISA because of the availability of IA enzyme conjugates from commercial sources. A number of solid phases have been used, including test tubes, microtiter plates, beads, filter paper discs, and resins. The type of solid phase will dictate the kinds of instrumentation to be used in manipulation of the various steps in the procedure. Immunoassays have been successfully applied for the detection of hepatitis A virus (HAV) [10] , hepatitis B virus (HBV) [11] , rotavirus [12, 13] , adenovirus [14, 15] , herpes simplex virus (HSV) [16, 17] , respiratory syncytial virus (RSV) [18] , influenza A virus [19, 20, 21] , cytomegalovirus (CMV) [22] , and Coxsackie viruses [23, 24] , and commercial kits are becoming available for several. Table 2 shows a small comparison of the ability of EIA and electron microscopy (EM) to detect rotavirus in stools from patients with gastroenteritis. Thus chromatography are probably the most accurate means available for the separation of IgM. However, these techniques are relatively complex, time-consuming, and expensive to perform. Consequently not many laboratories would employ them on a routine basis. Absorption of the serum with a preparation of staphylococcal protein A (SPA) has been used with varying success for the detection of rubella-specific IgM in order to diagnose recent infection [25] . Similarly, 2-mercaptoethanol has been used to destroy IgM in sera. A comparison is then made of treated and non-treated sera for the measurement of antibody responses. Both of these techniques, although easy to perform, have their problems with specificity of reaction. The products of separation in any of these methods are usually assayed in standard tests such as hemagglutination inhibition (HAI), RIA, ELISA, and so on.
There is a trend toward the development of assays which will separate and measure in the same test (Table 5) . IF was one of the earliest approaches to IgM measurement using infected cells to trap IgM from serum [26] [27] [28] [29] . This approach has the difficulties of creating a uniform expression of antigens and elimination of adsorption of immunoglobulins to Fc receptors expressed on the surface of virusinfected cells. Thus more recent approaches use inanimate solid phases (see section on antigen detection) and indicators conjugated with isotopes, enzymes, erythrocytes, or latex particles. Figure 7 illustrates the principles of IgM measurement using a capture antigen on the solid phase. The antigen may be adsorbed ability to hemagglutinate, erythrocytes can be used as indicators. Table 7 summarizes the various capture antibody systems that have been described [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] . A majority of the papers have appeared since 1978, and most are in the area of rubella serology. Tests for hepatitis A and rubella IgM have found their way into routine use due to commercial efforts. Figure 9 shows a modification of the capture antibody method employing an enzyme-labeled antigen [62] [63] [64] [65] [66] [67] . The technique has been described for CMV, EBV, VZV, and HSV (Table 8 ) and appears to have the advantages of simplicity as well as high levels of sensitivity and specificity. Another approach that has been described is shown in Fig. 10 . This competitive antibody blocking test passively adsorbs the test serum to the solid phase then blocks reactive sites in one of the wells before adding antigen and indicator. Differences are then indicative of IgM presence or absence.
Each system mentioned has its inherent problems and advantages [68] [69] [70] [71] [72] [73] . Table 9 summarizes the approaches that are required in the two systems to avoid false positive or negative results.
The best example of the use of solid-phase immunoassays employing systems for the detection of viral antigens and antibodies is that for viral hepatitis and is il- lustrated in Fig. 11 . A single serum collected during the acute phase of illness can be tested for hepatitis B surface antigen (HBsAg) and HAV IgM. The presence of either of these markers thus provides a diagnosis within a day. The presence of core antibody (anti-HBc) and absence of anti-HBs (antibody to surface antigen) may mean recent infection with HBV, and a second serum should be requested or a test performed on the first serum for anti-HBc IgM. By the process of elimination of HBV, HAV, CMV, and EBV the patient may be diagnosed as having non-A, non-B hepatitis. Assays for detection of markers of non-A, non-B may soon become available [74] . Using the tests illustrated in Fig. 11 we have had many occasions to perform "stat" testing on health care workers' and patients' sera involved in a needlestick accident and to provide recommendations for the appropriate use of hepatitis B immune globulin (HBIG). Similar testing has identified HBsAg mothers and recommendations for the use of HBIG and vaccine for their babies. Identification of HAV cases have enabled appropriate immunization of their close contacts with immune serum globulin. Diseases for which EM can play a role in rapid diagnosis include: gastroenteritis, herpes simplex infections, varicella zoster, variola, vaccinia, pustular contagious dermatitis, molluscum contagiosum, warts, and congenital cytomegalovirus (Table 10) .
Rotaviruses (Fig. 12) , adenoviruses, picornaviruses, astroviruses, caliciviruses, coronaviruses, and Norwalk agents have been viewed in feces from patients with gastroenteritis [76] . We use the technique on a daily basis to diagnose hospitalized patients upon admission for purposes of isolation and reduced nosocomial spread.
Patients presenting with vesicular lesions (ex-or enanthematous) may yield herpes simplex, varicella (Fig. 13) , or vaccinia viruses in vesicle fluid. The EM morphology of the herpes viruses allows identification to group, and other laboratory techniques are needed for typing. EM can be used to detect herpes virus particles in brain biopsy material from a patient with encephalitis ( Fig. 14) Cytomegalovirus (Fig. 15 ) is usually present in high concentration in the urine of congenitally infected infants [77] but may require some form of enhancement [78] .
The most appropriate laboratory technique for the preparation of clinical specimens is negative staining. Thin sectioning techniques have limited applicability to rapid diagnosis. However, a rapid embedding method that takes only two hours has been described [79] and thin sectioning is useful where speed of diagnosis is not important.
The basic requirements for negative staining have been described in detail by Almeida [80] . The most commonly used stain is phosphotungstic acid (PTA) as a 2-4 percent solution adjusted to a pH of 6 to 8, with 1 N potassium hydroxide, and stored as a working solution at 4°C. Formvar-carbon coated 400 mesh copper grids provide the most versatile characteristics for specimen viewing. A disposal container of hypochlorite or similar solution should be used for discarding contaminated materials and a flame present for decontamination of forceps.
Fluid specimens are centrifuged for one hour at 15,000 g with resuspension of the pellet in a small amount of distilled water before staining [81] . A more rapid and simpler technique involves placing a drop of the specimen on a drop of sterile distilled water sitting on a waxed surface (Fig. 16) to the drop, held upright, and stained with a drop of PTA. Excess fluid is removed with a torn strip of filter paper, after which the specimen is dried before examining in an EM. The total process takes about five minutes. Application of centrifugation is helpful in making a preparation of better quality and often depends on the type of clinical specimen submitted. Feces can be prepared by making a 10-20 percent suspension in distilled water. Clarification in a bench centrifuge may be necessary for some suspensions; however, rotaviruses are usually easily seen without centrifugation.
Vesicle fluid should be collected from unbroken lesions using a tuberculin syringe containing a small amount of distilled water. A sheath should be placed over the needle, and tape applied to the plunger and sheath; then the syringe should be transported to the laboratory inside an appropriate container. Urine which is cloudy should be clarified by centrifugation at 2,500 g for 30 minutes. The supernatant fluid will usually yield virus more readily if as large a volume as possible is centrifuged for one hour at 15,000 g with staining of the resuspended pellet. Techniques of enhancement have proven useful for urine specimens. Serum contains many low molecular weight proteins which need to be washed out by diluting with an equal volume of distilled water. The centrifugation step is necessary and may require recentrifugation to enable a clean specimen.
Biopsy or autopsy tissue is cut into small (1 mm) cubes and placed on a metal planchet, which enables several cycles of freezing and thawing. An [82] . Both of these specimens should be processed by the rapid staining technique. Sputum specimens should be diluted in saline and then homogenized or treated with 20 percent n-acetyl cystein. Differential centrifugation or some form of enhancement is usually necessary to concentrate the specimen. If concentrations of viruses are lower in these specimens or others, techniques to enhance visualization are necessary (Table 11 ). Both pseudoreplication [83] and gel diffusion [84] concentrate the virus particles by allowing the fluid phase to pass through agar. Using ultracentrifugation techniques, both influenza A and parainfluenza 3 viruses were seen in throat washings from patients (Figs. 17 and 18) . Using solid phase immune electron microscopy techniques [85] we were able to concentrate BK virus 100-to 1,000-fold (Fig. 19) . Similarly, by coating SPA treated grids with rabbit antiserum to CMV, the method was able to detect virus in urine from CMV-infected kidney allograft patients (Fig. 20) . 
